Germany· DE-A57-683c61c7f2c797df
Indium (In111) Oxinate Curium Netherlands
A medicinal product containing indium (111in) oxine, registered in Germany by Curium Netherlands B.V..
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indium (111in) Oxine
- Manufacturer
- Curium Netherlands B.V.
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indium (111in) oxine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIndium in 111 OxyquinolineMedi-Physics Inc. dba GE Healthcare.
- CzechiaINDIUM (IN111) OXINATECurium Netherlands B.V., Petten
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Indium (111in) Oxinate Curium, Indium-(111in) Oxinate Curium
- Denmark · Indium (In-111) Oxinate
- Spain · Indio (111in) Oxina Curium Pharma Spain
- France · Oxinate D’indium (111in) Curiumpharma
- Italy · Indio (111in) Ossina
- Netherlands · Indium (In111) Oxinate Drn 4908 Curium Netherlands B.V.
- Sweden · Indium (In111) Oxinat Curiumpharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97c665ac-ff71-4fd7-8ae0-0f46a301022a GET /v1/drugs/97c665ac-ff71-4fd7-8ae0-0f46a301022a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indium (111in) Oxine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indium (111in) oxine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.